Nicolas Moosmann

Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104—A Randomized Trial of the German AIO CRC Study Group

Nicolas Moosmann, Ludwig Fischer von Weikersthal, Ursula Vehling‐Kaiser et al. · Journal of Clinical Oncology · 2011 · 116 citations

Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial

Beate Rau, Hauke Lang, Alfred Koenigsrainer et al. · Journal of Clinical Oncology · 2023 · 113 citations · Full text

Randomized phase III trial of induction chemotherapy followed by chemoradiotherapy or chemotherapy alone for nonresectable locally advanced pancreatic cancer: First results of the CONKO-007 trial.

Rainer Fietkau, Michael Ghadimi, Robert Grützmann et al. · Journal of Clinical Oncology · 2022 · 108 citations

Surgical Oncology, Cancer Management, Gastroenterology +17

Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: Results from a randomized trial of the GERMAN AIO CRC Study Group

Sebastian Stintzing, Christine Kapaun, Rüdiger P. Laubender et al. · International Journal of Cancer · 2012 · 80 citations · Full text

Oral Capecitabine in Gemcitabine-Pretreated Patients with Advanced Pancreatic Cancer

Stefan Boeck, Ralf Wilkowski, Christiane J. Bruns et al. · Oncology · 2007 · 55 citations · Full text